Entero Therapeutics Inc.’s recently made public that its Chief Financial Officer Romano Sarah unloaded Company’s shares for reported $664.0 on Jul 02 ’24. In the deal valued at $1.07 per share,621 shares were sold. As a result of this transaction, Romano Sarah now holds 18,490 shares worth roughly $11094.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SAPIRSTEIN JAMES sold 1,289 shares, generating $1,379 in total proceeds. Upon selling the shares at $1.07, the Chairman and CEO now owns 35,816 shares.
Before that, SAPIRSTEIN JAMES sold 174 shares. Entero Therapeutics Inc. shares valued at $736 were divested by the Chairman and CEO at a price of $4.23 per share. As a result of the transaction, SAPIRSTEIN JAMES now holds 37,105 shares, worth roughly $22263.0.
Price Performance Review of ENTO
On Friday, Entero Therapeutics Inc. [NASDAQ:ENTO] saw its stock jump 72.12% to $0.60. Over the last five days, the stock has gained 74.48%. Entero Therapeutics Inc. shares have fallen nearly -85.72% since the year began. Nevertheless, the stocks have fallen -89.90% over the past one year. While a 52-week high of $14.51 was reached on 03/01/24, a 52-week low of $0.19 was recorded on 08/08/24. SMA at 50 days reached $0.4156, while 200 days put it at $2.8199.
Levels Of Support And Resistance For ENTO Stock
The 24-hour chart illustrates a support level at 0.3900, which if violated will result in even more drops to 0.1804. On the upside, there is a resistance level at 0.7796. A further resistance level may holdings at 0.9596. The Relative Strength Index (RSI) on the 14-day chart is 71.47, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0717, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 34.14%. Stochastics %K at 47.23% indicates the stock is a holding.
How much short interest is there in Entero Therapeutics Inc.?
A steep rise in short interest was recorded in Entero Therapeutics Inc. stocks on 2024-09-13, dropping by -0.27 million shares to a total of 0.13 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 0.39 million shares. There was a decline of -209.21%, which implies that there is a negative sentiment for the stock.
